10-Q Filing

BEONE MEDICINES LTD. CIK: 1651308 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001651308-19-000045`
Period End Date	20190331
Filing Date	20190509
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	bgne-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 96 Income Statement 36 Cash Flow Statement 91 Stockholders Equity 20 Comprehensive Income 12

Balance Sheet 96 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	9.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$764.49M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$490.63M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	776.26M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.90M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesIssued`	777.41M	shares	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$17.46M	USD	Point-in-time
Short-term restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$849.17M	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	777.41M	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$1.07B	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$58.98M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$41.06M	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$8.61M	USD	Point-in-time
Unbilled receivable	`UnbilledReceivablesCurrent`	$6.11M	USD	Point-in-time
Inventories	`InventoryNet`	$13.14M	USD	Point-in-time
Inventories	`InventoryNet`	$16.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$89.94M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$81.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.80B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.94B	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$8.99M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$197.81M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$157.06M	USD	Point-in-time
Land use right, net	`LandUseRightNet`	$45.06M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$72.62M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.04M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$6.84M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$7.17M	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Goodwill	`Goodwill`	$109.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$29.54M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$30.53M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$53.67M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$58.60M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$305.84M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$375.50M	USD	Point-in-time
Total assets	`Assets`	$2.25B	USD	Point-in-time
Total assets	`Assets`	$2.17B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$113.28M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$105.32M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$90.74M	USD	Point-in-time
Accrued expenses and other payables	`AccountsPayableAndAccruedLiabilitiesCurrent`	$100.41M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$18.14M	USD	Point-in-time
Deferred revenue, current portion	`ContractWithCustomerLiabilityCurrent`	$17.50M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$5.89M	USD	Point-in-time
Tax payable	`TaxesPayableCurrent`	$6.86M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$8.68M	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$9.45M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.94M	USD	Point-in-time
Current portion of long-term bank loan	`LongTermDebtCurrent`	$8.73M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$238.81M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$246.45M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$40.78M	USD	Point-in-time
Long-term bank loan	`LongTermDebtNoncurrent`	$77.48M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$148.89M	USD	Point-in-time
Shareholder loan	`DueToRelatedPartiesNoncurrent`	$155.17M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$8.24M	USD	Point-in-time
Deferred revenue, non-current portion	`ContractWithCustomerLiabilityNoncurrent`	$9.84M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$19.55M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.33M	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$11.14M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.97M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$38.93M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$249.59M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$310.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$549.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$496.04M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 777,413,184 and 776,263,184 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$78.00K	USD	Point-in-time
Ordinary shares, US$0.0001 par value per share; 9,500,000,000 shares authorized; 777,413,184 and 776,263,184 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	`CommonStockValue`	$77.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.78B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.74B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.07M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.74B	USD	Point-in-time
Total BeiGene, Ltd. shareholders equity	`StockholdersEquity`	$1.61B	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$14.45M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$13.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.17B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$2.25B	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$77.83M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$32.54M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$15.26M	USD	1 Quarter
Cost of sales - product	`CostOfGoodsAndServicesSold`	$4.55M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$178.35M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$109.70M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$57.65M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.91M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$331.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$188.00K	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$251.59M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$143.35M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-110.81M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-173.75M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$4.48M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$1.55M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$1.73M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$729.00K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-108.53M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-167.55M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-3.41M	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$519.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-429.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-520.00K	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-167.64M	USD	1 Quarter
Net loss attributable to BeiGene, Ltd.	`NetIncomeLoss`	$-104.60M	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	774.75M	shares	1 Quarter
Weighted-average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	670.51M	shares	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.81	USD	1 Quarter
Net loss per American Depositary Share (ADS), basic and diluted (in dollars per share)	`EarningsPerAmericanDepositoryShare`	$-2.03	USD	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberofAmericanDepositorySharesOutstanding`	59.60M	shares	1 Quarter
Weighted-average ADSs outstanding, basic and diluted (shares)	`WeightedAverageNumberofAmericanDepositorySharesOutstanding`	51.58M	shares	1 Quarter

Cash Flow Statement 91 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$2.24M	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$3.42M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$17.40M	USD	1 Quarter
Share-based compensation expenses	`ShareBasedCompensation`	$26.39M	USD	1 Quarter
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.00M	USD	1 Quarter
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$29.00M	USD	1 Quarter
Non-cash interest expense	`InterestExpenseOperatingActivities`	$2.01M	USD	1 Quarter
Non-cash interest expense	`InterestExpenseOperatingActivities`	$1.86M	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-983.00K	USD	1 Quarter
Deferred income tax benefits	`DeferredIncomeTaxesAndTaxCredits`	$-4.09M	USD	1 Quarter
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$810.00K	USD	1 Quarter
Disposal gain on available-for-sale securities	`MarketableSecuritiesRealizedGainLoss`	$482.00K	USD	1 Quarter
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	$-2.41M	USD	1 Quarter
Non-cash amortization of bond discount	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.94M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.92M	USD	1 Quarter
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$7.55M	USD	1 Quarter
Unbilled receivable	`IncreaseDecreaseInContractWithCustomerAsset`	$-2.50M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-3.43M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-3.10M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.76M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$8.27M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	$1.59M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightofUseAsset`	-	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$2.08M	USD	1 Quarter
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$10.21M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-18.49M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-20.36M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$6.12M	USD	1 Quarter
Accrued expenses and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-8.79M	USD	1 Quarter
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$733.00K	USD	1 Quarter
Tax payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$969.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-2.24M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-1.74M	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$892.00K	USD	1 Quarter
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$933.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$1.55M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-104.50M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-171.97M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.70M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.83M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$632.22M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$487.35M	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$710.60M	USD	1 Quarter
Proceeds from sale or maturity of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$257.57M	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$10.00M	USD	1 Quarter
Purchase of in-process research and development	`PaymentsToPurchaseInProcessResearchAndDevelopment`	$29.00M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$172.42M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-394.35M	USD	1 Quarter
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	$758.00M	USD	1 Quarter
Proceeds from follow-on public offering, net of underwriter discount	`ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount`	-	USD	1 Quarter
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	$414.00K	USD	1 Quarter
Payment of follow-on public offering cost	`PaymentsOfStockIssuanceCosts`	-	USD	1 Quarter
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	-	USD	1 Quarter
Proceeds from long-term loan	`ProceedsFromLongTermLinesOfCredit`	$36.70M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$6.27M	USD	1 Quarter
Proceeds from option exercises and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$6.31M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$42.96M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$763.90M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.44M	USD	1 Quarter
Effect of foreign exchange rate changes, net	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.26M	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$268.49M	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$47.67M	USD	1 Quarter
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$788.38M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$508.09M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$239.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$740.71M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$788.38M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$508.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$712.94M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$764.49M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$490.63M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.90M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$17.46M	USD	Point-in-time
Restricted cash, current	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$14.54M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$8.99M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$13.23M	USD	Point-in-time
Long-term restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	-	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$329.00K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$360.00K	USD	1 Quarter
Interest expense paid	`InterestPaidNet`	$331.00K	USD	1 Quarter
Interest expense paid	`InterestPaidNet`	$888.00K	USD	1 Quarter
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$3.64M	USD	1 Quarter
Acquisitions of equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$32.46M	USD	1 Quarter
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	$-2.29M	USD	1 Quarter
Changes in operating assets and liabilities adjusted through accumulated deficit	`CumulativeEffectOnRetainedEarningsNetOfTax1`	-	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	777.41M	shares	Point-in-time
Balance at the beginning of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.27M	USD	1 Quarter
Exercise of options, ESPP and release of Restricted Share Units (RSUs)	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.31M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.39M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$17.40M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$4.44M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$601.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	777.41M	shares	Point-in-time
Balance at the ending of period (in shares)	`CommonStockSharesOutstanding`	776.26M	shares	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.36B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.75B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.62B	USD	Point-in-time
Balance at the end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$684.23M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-168.07M	USD	1 Quarter
Net loss	`ProfitLoss`	$-105.12M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$272.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.75M	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$329.00K	USD	1 Quarter
Unrealized holding gain, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$685.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-163.63M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-104.52M	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-535.00K	USD	1 Quarter
Less: comprehensive loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-456.00K	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-104.06M	USD	1 Quarter
Comprehensive loss attributable to BeiGene, Ltd.	`ComprehensiveIncomeNetOfTax`	$-163.09M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.